263 related articles for article (PubMed ID: 26455545)
1. Demyelination preceding a diagnosis of central nervous system lymphoma.
Kalus S; Di Muzio B; Gaillard F
J Clin Neurosci; 2016 Feb; 24():146-8. PubMed ID: 26455545
[TBL] [Abstract][Full Text] [Related]
2. Prolonged interval between sentinel pseudotumoral demyelination and development of primary CNS lymphoma.
Ng S; Butzkueven H; Kalnins R; Rowe C
J Clin Neurosci; 2007 Nov; 14(11):1126-9. PubMed ID: 17890092
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory demyelinating brain lesions heralding primary CNS lymphoma.
Husseini L; Saleh A; Reifenberger G; Hartung HP; Kieseier BC
Can J Neurol Sci; 2012 Jan; 39(1):6-10. PubMed ID: 22384490
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory Demyelinating Lesions: True Sentinel Lesion or Immune-Mediated Response to Lymphoma?
Qiu T; Chanchotisatien A; Qin Z; Wu J; Chu S
World Neurosurg; 2021 Jan; 145():172-177. PubMed ID: 32949800
[TBL] [Abstract][Full Text] [Related]
5. Demyelination as a harbinger of lymphoma: a case report and review of primary central nervous system lymphoma preceded by multifocal sentinel demyelination.
Kvarta MD; Sharma D; Castellani RJ; Morales RE; Reich SG; Kimball AS; Shin RK
BMC Neurol; 2016 May; 16():72. PubMed ID: 27206499
[TBL] [Abstract][Full Text] [Related]
6. Primary Central Nervous System Lymphoma with Associated Demyelination and Creutzfeldt Astrocytes.
Achi HE; Lally JE; Riascos RF; Zhu JJ; Tandon N; Esquenazi Y; Bhattacharjee MB; Ballester LY
Ann Clin Lab Sci; 2018 Jul; 48(4):534-537. PubMed ID: 30143499
[TBL] [Abstract][Full Text] [Related]
7. Primary central nervous system lymphoma in immunocompetent patients: a retrospective review of MRI features.
Sutherland T; Yap K; Liew E; Tartaglia C; Pang M; Trost N
J Med Imaging Radiat Oncol; 2012 Jun; 56(3):295-301. PubMed ID: 22697326
[TBL] [Abstract][Full Text] [Related]
8. Central nervous system lymphoma initially diagnosed as tumefactive multiple sclerosis after brain biopsy.
Ohe Y; Hayashi T; Mishima K; Nishikawa R; Sasaki A; Matsuda H; Uchino A; Tanahashi N
Intern Med; 2013; 52(4):483-8. PubMed ID: 23411706
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance features of primary central nervous system lymphoma in the immunocompetent patient: a pictorial essay.
Yap KK; Sutherland T; Liew E; Tartaglia CJ; Pang M; Trost N
J Med Imaging Radiat Oncol; 2012 Apr; 56(2):179-86. PubMed ID: 22498191
[TBL] [Abstract][Full Text] [Related]
10. Conventional and advanced magnetic resonance imaging in tumefactive demyelination.
Saini J; Chatterjee S; Thomas B; Kesavadas C
Acta Radiol; 2011 Dec; 52(10):1159-68. PubMed ID: 22025739
[TBL] [Abstract][Full Text] [Related]
11. Performance of Apparent Diffusion Coefficient Values and Conventional MRI Features in Differentiating Tumefactive Demyelinating Lesions From Primary Brain Neoplasms.
Mabray MC; Cohen BA; Villanueva-Meyer JE; Valles FE; Barajas RF; Rubenstein JL; Cha S
AJR Am J Roentgenol; 2015 Nov; 205(5):1075-85. PubMed ID: 26496556
[TBL] [Abstract][Full Text] [Related]
12. Primary CNS Lymphoma vs. Tumefactive Multiple Sclerosis: A Diagnostic Challenge.
Naeem SB; Niazi F; Baig A; Sadiq H; Sattar M
J Coll Physicians Surg Pak; 2018 Jan; 28(1):66-68. PubMed ID: 29290197
[TBL] [Abstract][Full Text] [Related]
13. Neuroinflammation Preceding and Accompanying Primary Central Nervous System Lymphoma: Case Study and Literature Review.
Lu JQ; O'Kelly C; Girgis S; Emery D; Power C; Blevins G
World Neurosurg; 2016 Apr; 88():692.e1-692.e8. PubMed ID: 26724610
[TBL] [Abstract][Full Text] [Related]
14. Demyelinating lesions behaving like aggressive tumours on advanced MRI techniques.
Barbosa BC; Marchiori E; Leal Leidersnaider C; Brandao L; Castillo M
Neuroradiol J; 2019 Apr; 32(2):103-107. PubMed ID: 30667319
[TBL] [Abstract][Full Text] [Related]
15. Clinical and magnetic resonance imaging (MRI) distinctions between tumefactive demyelination and brain tumors in children.
Yiu EM; Laughlin S; Verhey LH; Banwell BL;
J Child Neurol; 2014 May; 29(5):654-65. PubMed ID: 24092896
[TBL] [Abstract][Full Text] [Related]
16. Histopathological variation in the demyelinating sentinel lesion of primary central nervous system lymphoma.
Bajagain M; Oyoshi T; Hanada T; Higa N; Hiraki T; Kamimura K; Kuroki S; Yoshimoto K
Surg Neurol Int; 2020; 11():342. PubMed ID: 33194276
[TBL] [Abstract][Full Text] [Related]
17. Tumefactive demyelinating lesion: experience with two unusual patients.
Sinha MK; Garg RK; Bhatt ML; Chandra A
J Postgrad Med; 2010; 56(2):146-9. PubMed ID: 20622396
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory brain lesions preceding primary central nervous system lymphoma: a case report and genetic analysis.
XiaoHong Z; Shuo Y; GeHong D; AnChao Y; Ce W; YunYun D; Can W; SiJie H; Feng C; WenBin L
Neurol Sci; 2023 May; 44(5):1555-1561. PubMed ID: 36599976
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory Brain Lesions as Omen of Primary Central Nervous System Lymphoma: A Case Report and Literature Review.
Kim YJ; Kim SK; Jung TY; Kim IY; Lee KH; Moon KS
Brain Sci; 2021 Feb; 11(2):. PubMed ID: 33557224
[TBL] [Abstract][Full Text] [Related]
20. Tumefactive Demyelination versus Primary Central Nervous System Lymphoma on
Biswas S; Nagaraj C; Mangalore S; Gupta AK
Indian J Nucl Med; 2019; 34(3):237-240. PubMed ID: 31293309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
